Collplant Biotechnologies Ltd Cash Flow Quality Index

Latest as of June 2023: -0.65x

Collplant Biotechnologies Ltd cash flow quality index. Collplant Biotechnologies Ltd (CLGN) has a Cash Flow Quality Index of -0.65x as of June 2023. Operating cash flow of $-3.74 Million is below net income of $5.76 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Collplant Biotechnologies Ltd to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.65x

Operating CF / Net Income

Operating Cash Flow

$-3.74 Million

USD

Net Income

$5.76 Million

USD

Data as of

Jun 2023

Most recent filing

Cash Flow Quality Index of Collplant Biotechnologies Ltd (2021–2021)

Cash flow quality index of Collplant Biotechnologies Ltd from 2021 to 2021. Historical Cash Flow Quality Index for Collplant Biotechnologies Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CLGN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Collplant Biotechnologies Ltd Cash Flow Quality Index by Year (2021–2021)

Collplant Biotechnologies Ltd cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Collplant Biotechnologies Ltd. For the full cash flow conversion analysis, see Collplant Biotechnologies Ltd operating cash flow efficiency.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2021	10.55x	$2.50 Million	$237.00K	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.